• SENSEX 80,692.93
    -17.32 (--0.02%)
  • BANKNIFTY 55,360.25
    -259.10 (--0.47%)
  • Bikaji Foods
    721.20 520.00(%)
  • Transrail Light
    800.00 807.00(%)
  • Godfrey Phillips
    10,867.50 9,891.25(%)
  • Newgen Software
    977.35 1,795.50(%)
  • Waaree Energies
    3,234.80 3,740.75(%)
  • Jayaswal Neco
    52.82 26.06(%)
  • Reliance Power
    43.06 29.21(%)
  • Aditya Infotech
    1,025.20 1,014.65(%)
  • Le Travenues
    226.80 118.65(%)
  • Bharti Airtel
    1,965.00 2,045.50(%)
  • Tata Motors
    650.45 542.55(%)
  • NCC
    220.80 334.15(%)
  • Mazagon Dock
    2,761.00 1,917.95(%)
  • Zinka Logistics
    569.90 548.00(%)
  • Swiggy
    398.70 617.00(%)
  • Larsen & Toubro
    3,628.85 2,967.65(%)
  • Kirloskar Oil
    945.00 1,404.95(%)
  • HDFC Bank
    1,983.15 2,036.30(%)
  • One 97
    1,070.60 1,128.00(%)
  • Trent
    5,425.00 8,345.85(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lasa Supergenerics Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 67941.0
  • ISIN : INE670X01014
10.24 0 (1.99%)
  • As on 06 Aug 2025 (EOD)

  • Today’s Low

    10.24

  • Today’s High

    10.24

  • Open

    10.24

  • Perv Close

    10.04

  • 52W Low

    8.42

  • 52W High

    33.49

Key Indicators

  • P/E(TTM)

    57.22

  • Mar.Cap (₹Cr.)

    51.30

  • Div & Yield %

    0.00

  • Book Value(₹)

    16.71

  • Debt-Equity Ratio

    1.99

  • AGM Date

    05-Aug-2025

  • EPS

    0.18

  • P/E Ratio

    57.22

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    51.30

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    50.10

  • BV (₹)

    16.70

  • Sales( ₹ in Cr.)

    142.45

  • NP (in Cr.)

    0.91

  • NP Var(%)

    106.0

  • Div%

    0.0

  • CPS (₹)

    2.60

  • EPS (₹)

    0.20

  • Traded Value (₹ in Lakhs)

    51.60

  • 52 Week High

    33.49

  • 52 Week Low

    8.42

  • Price BSE

    10.0

  • Price NSE

    10.00

  • Market Capital( in Cr.)

    51.60

  • P/C Ratio

    3.80

  • P/E Ratio

    54.90

  • Price Vs.BV

    0.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 104.34 129.57 137.13 202.38 167.27 169.57
Excise Duty 0.00 0.00 0.00 0.00 0.01 0.00
Net Sales 104.34 129.57 137.13 202.38 167.26 169.57
Other Income 0.10 1.80 0.27 0.06 0.23 0.47
Stock Adjustments 4.06 4.01 3.17 -10.24 -7.65 -1.74
Total Income 108.50 135.38 140.57 192.20 159.84 168.30
EXPENDITURE :            
Raw Materials 79.28 110.12 94.46 102.11 87.01 126.21
Power and Fuel Cost 7.45 7.72 7.06 8.06 7.92 6.71
Employee Cost 5.37 6.35 7.15 14.01 13.42 11.74
Other Manufacturing Expenses 8.02 6.24 5.36 9.94 7.95 6.05
Selling and Administration Expenses 5.64 6.98 9.03 9.72 6.54 4.65
Miscellaneous Expenses 9.19 22.63 9.07 0.98 6.82 1.36
Employee Benefit Expenses 5.37 6.35 7.15 14.01 13.42 11.74
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 114.95 160.03 132.13 144.82 129.65 156.72
Operating Profit -6.45 -24.66 8.43 47.38 30.20 11.59
Interest 1.99 4.19 0.06 2.06 8.12 8.38
Gross Profit -8.44 -28.85 8.37 45.32 22.08 3.21
Depreciation 10.67 13.42 14.51 15.82 17.34 19.31
Profit Before Tax -19.11 -42.27 -6.14 29.50 4.74 -16.10
Current Tax 0.00 0.04 0.65 1.07 1.28 0.61
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.62 -3.69 -1.46 5.65 -0.17 -4.68
Reported Net Profit -21.73 -38.62 -5.33 22.78 3.63 -12.03
Extraordinary Items -7.57 -19.22 -7.79 -0.01 -0.17 0.00
Adjusted Net Profit -14.16 -19.40 2.46 22.79 3.80 -12.03
Adjustment below Net Profit 0.12 0.04 0.06 -5.33 0.04 -0.01
P & L Balance brought forward -25.37 14.23 20.52 3.28 -0.39 11.66
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 1.02 1.02 0.00 0.00 0.00
P & L Balance carried down -46.98 -25.37 14.23 20.73 3.28 -0.39
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 2.50 2.50 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.25 0.25 0.00 0.00
Earnings Per Share-Unit Curr -4.34 -7.71 -1.06 5.60 0.89 0.00
Earnings Per Share(Adj)-Unit Curr -4.34 -7.71 -1.06 5.60 0.89 0.00
Book Value 19.30 23.61 31.51 39.07 34.78 46.05
Book Value(Adj)-Unit Curr 19.30 23.61 31.51 39.07 34.78 46.05

Shareholding Pattern

  • Promoter Group

    53.65%

  • Public Share Holding

    46.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 26,879,660 53.65 26,879,660 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 26,879,660 53.65 26,879,660 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 522,641 1.04 522,641 97
Clearing Members 82,389 0.16 82,389 16
Directors of their Relatives 41,225 0.08 41,225 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 372,216 0.74 371,266 298
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,295,531 2.59 1,295,531 584
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,685,003 7.36 3,685,003 80
Individuals holding nominal share capital up to Rs. 1 lakh 13,390,340 26.73 13,387,569 26,108
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 11 0.00 11 1
Others 0 0.00 0 0
Sub Total 23,221,579 46.35 23,207,858 27,187
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 50,101,239 100.00 50,087,518 27,188

Company Background

Lasa Supergenerics LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Lasa Supergenerics Ltd
  • BSE Code : 67941.0
  • ISIN : INE670X01014

  • Incorporation Year

    2016

  • Registered Office

    C-105 MIDC
    Mahad, Raigad,
    Maharashtra-402301

  • Telephone

    91-2145-232101/232202

  • FAX

  • Chairman

    Omkar P Herlekar

  • Managing Director

    Omkar P Herlekar

  • Company Secretary

    Mitti M Jain

  • Auditor

    Thanawala & Co/Gupta Rustagi & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Lasa Supergenerics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lasa Supergeneri 10.30 104.43 104.34 -3.49 0.00
Abbott India 33,260.70 6,684.73 6,409.15 49.97 44.95
Astrazeneca Phar 8,853.35 1,756.92 1,716.29 191.22 32.94
P & G Health Ltd 6,185.55 1,166.89 1,151.26 34.16 39.76
Glaxosmi. Pharma 2,840.30 3,866.05 3,723.49 51.08 58.72
Cipla 1,499.25 20,029.57 19,044.85 22.41 21.40
Amrutanjan Healt 688.35 437.58 421.23 39.16 20.84
Fermenta Biotec. 360.00 442.21 430.53 15.67 17.61
Guj. Themis Bio. 358.25 174.19 169.82 87.59 44.82
Bliss GVS Pharma 179.40 703.42 667.20 26.82 9.16
Ambalal Sarabhai 32.11 19.33 4.04 29.73 2.10